NeoVac DA2This page contains information on NeoVac DA2 for veterinary use.
The information provided typically includes the following:
- NeoVac DA2 Indications
- Warnings and cautions for NeoVac DA2
- Direction and dosage information for NeoVac DA2
NeoVac DA2This treatment applies to the following species:
Canine Distemper-Adenovirus Type 2 Vaccine
Modified Live Virus
Directions For Use
For use as an aid in the prevention of disease due to Canine Distemper Virus and Canine Adenovirus Type 1 (infectious canine hepatitis virus). Aseptically rehydrate vaccine with diluent supplied. Inject 1 dose (1 mL) subcutaneously into dogs at least 42 days of age. Because there is potential for maternal antibody to interfere with the immune response to the original vaccination, revaccinate every 14 to 28 days until the dog is 16 weeks of age. Dogs over 16 weeks of age should receive a single dose (1 mL). Revaccinate annually with one dose.
PrecautionsStore at 2-7°C (35-45°F). Shake well during rehydration. Do not vaccinate pregnant or lactating bitches, sick, or debilitated dogs. Occasionally, transient corneal opacity may occur following the administration of this product. In case of anaphylaxis; epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction. Gentamicin used as a preservative. Burn this container and all unused contents.
U.S. Veterinary License No. 472
Product Code: 13A1.20
NEOTECH, LLC, Dresden, TN 38225 USA
25x1 Dose (1 mL) Vials of Vaccine - 25x1 mL Vials of Sterile Diluent
1x10 Dose (10 mL) Vial of Vaccine - 1x10 mL Vial of Sterile Diluent
NAC No.: 12670020
10061 HWY 22, DRESDEN, TN, 38225
|Every effort has been made to ensure the accuracy of the NeoVac DA2 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-01-09